Early breast cancer drug offers hope

A STUDY has confirmed that women with early breast cancer get significant benefits from taking the new drug Arimidex.

Switching to this after two years of standard tamoxifen treatment improves event-free survival for post-menopausal women.

Arimidex has been available in Ireland for the last six months and is used to treat patients in specialist units and during early stage breast cancer.